nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy
|
Yao, Isaac |
|
2019 |
202 |
C |
p. 32-39 |
artikel |
2 |
Chronopharmacological strategies focused on chrono-drug discovery
|
Ohdo, Shigehiro |
|
2019 |
202 |
C |
p. 72-90 |
artikel |
3 |
Cognitive dysfunction in major depression: From assessment to novel therapies
|
Atique-Ur-Rehman, Hafsa |
|
2019 |
202 |
C |
p. 53-71 |
artikel |
4 |
Drugging K-RasG12C through covalent inhibitors: Mission possible?
|
Ni, Duan |
|
2019 |
202 |
C |
p. 1-17 |
artikel |
5 |
Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness
|
Terlizzi, Michela |
|
2019 |
202 |
C |
p. 140-148 |
artikel |
6 |
Editorial Board
|
|
|
2019 |
202 |
C |
p. ii |
artikel |
7 |
Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)
|
Volonté, Cinzia |
|
2019 |
202 |
C |
p. 120-131 |
artikel |
8 |
Laminin-derived peptides: Applications in drug delivery systems for targeting
|
Negishi, Yoichi |
|
2019 |
202 |
C |
p. 91-97 |
artikel |
9 |
Live cell imaging of signaling and metabolic activities
|
Depaoli, Maria R. |
|
2019 |
202 |
C |
p. 98-119 |
artikel |
10 |
Molecular mechanisms of cereblon-based drugs
|
Asatsuma-Okumura, Tomoko |
|
2019 |
202 |
C |
p. 132-139 |
artikel |
11 |
Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease – frontiers and horizons
|
Jee, Adelle S. |
|
2019 |
202 |
C |
p. 40-52 |
artikel |
12 |
TP53 in bone and soft tissue sarcomas
|
Thoenen, Elizabeth |
|
2019 |
202 |
C |
p. 149-164 |
artikel |
13 |
Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics
|
Gill, Jason H. |
|
2019 |
202 |
C |
p. 18-31 |
artikel |